Replies to post #462 on Zynerba Pharmaceuticals (ZYNE)

[djmurdock]

Almost at the high of the day too, beautiful close. At current levels zyne is still almost half of its IPO pricing, with all the positive results coming in and still a low float there's a lot of room to grow.